Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Details)

v3.24.3
NET LOSS PER SHARE (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
NET LOSS PER SHARE                
Net Income (Loss) $ (14,664,719) $ (919,371) $ (26,641,983) $ (17,520,378) $ (10,178,640) $ (7,190,470) $ (42,226,073) $ (34,889,488)
Dilutive effect of warrant liability (1,428,355)           (7,283,786)  
Net loss allocated to common shares $ (16,093,074)           $ (49,509,859)  
Weighted average common shares outstanding - basic 39,335,924     11,308,738     34,850,441 11,277,231
Dilutive effect of warrant liability 458,296           695,060  
Weighted average common shares outstanding - diluted 39,794,220     11,308,738     35,545,500 11,277,231
Net loss per share - diluted $ (0.40)     $ (1.55)     $ (1.39) $ (3.09)